Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992-2008

Human Vaccines

Volumn 7, Issue SUPPL., 2011, Pages 234-239

  Micheletti, Fabiola ^a   Moretti, Ugo ^b   Tridente, Giuseppe ^c   Zanoni, Giovanna ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

AEFI (adverse events following immunisation); Consultancy; Immunisation; Surveillance; Vaccine safety

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA TETANUS VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; TETANUS TOXOID; VACCINE; VIRUS VACCINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ADVERSE OUTCOME; ANOREXIA; ARTHRALGIA; ARTHRITIS; ASTHENIA; BRONCHOSPASM; CAUSAL ATTRIBUTION; CLINICAL EVALUATION; CONSULTATION; CONTROLLED STUDY; CONVALESCENCE; DIARRHEA; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DIZZINESS; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG SAFETY; FAINTNESS; FEBRILE CONVULSION; FEVER; FOLLOW UP; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; INJECTION SITE REACTION; IRRITABILITY; ITALY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAISE; MASS IMMUNIZATION; MUSCLE HYPOTONIA; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; PALLOR; PAROTID ENLARGEMENT; PATHOLOGICAL CRYING; PRURITUS; RASH; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SKIN MANIFESTATION; SOMNOLENCE; SYSTEMIC DISEASE; THROMBOCYTOPENIA; TREND STUDY; URTICARIA; VACCINATION REACTION; VASCULITIS; VOMITING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; ITALY; REFERRAL AND CONSULTATION; VACCINATION; VACCINES;

EID: 80051886441     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.0.14613     Document Type: Review

References (16)

1. Offit PA, Davis RL, Gust D. Vaccine safety. In: Plotkin SA, Orenstein WA, Offit PA, Eds. Vaccines. Fifth edition. Saunders Elsevier 2008; 1629-50.
2. Immunization safety surveillance: guidelines for managers of immunisation programmes on reporting and investigating adverse events following immunisation. WPRO/EPI/99.01. Manila: WHO Regional Office for the Western Pacific 1999.
3. Global Advisor Committee on Vaccine Safety. WHO [available from http://www.who.int/vaccine safety/en/].
4. Chen RT. Evaluation of vaccine safety after the events of 11 September 2001: role of a cohort and case-control studies. Vaccine 2004; 22:2047-53.
5. Zanoni G, Berra P, Lucchi I, Ferro A, O'Flanagan D, Levy-Bruhl D, et al. Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts. Vaccine 2009; 27:3376-84.
6. Zanoni G, Ferro A, Valsecchi M, Tridente G. The "Green Channel" of the Veneto region as a model for vaccine safety monitoring in Italy. Vaccine 2005; 23:2354-8. (Pubitemid 40341483)
7. Wood RA, Berger M, Dreskin SC, Setse R, Engler RJM, Dekker CL, et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 2008; 122:771-7.
8. th Edition. Philadelphia: Mosby, Ed 2009; 1189-204.
9. Rüggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, et al. Anaphylaxis: case definition and guidelines for data collection, analysis and presentation of immunisation safety data. Vaccine 2007; 25:5675-84. (Pubitemid 47049764)
10. Zanoni G, Puccetti A, Dolcino M, Simone R, Peretti A, Ferro A, et al. Dextran-specific IgG response in hyper-sensitivity reactions to measles-mumps-rubella vaccine. J Allergy Clin Immunol 2008; 122:1233-5.
11. Schumacher Z, Bourquin C, Heininger U. Surveillance for adverse events following immunisation (AEFI) in Switzerland 1991-2001. Vaccine 2010; 28:4059-64.
12. Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Commun Dis Intell 2009; 33:365-81.
13. van der Maas NAT, Oostvogels B, PHaff TAJ, Wesselo C, Vermeer-de Bondt PE. Adverse events following immunisation under the National Vaccination Programme of the Netherlands. Number XV-Reports in 2008 RIVM rapport 205021005/2010 http://www.rivm.nl/bibliotheek/rapporten/205021005.pdf
14. Postila V, Kilpi T. Use of vaccine surveillance data in the evaluation of safety of vaccines. Vaccine 2004;22:2076-9. (Pubitemid 38581084)
15. Black S. Global Vaccine Safety DataNet meeting. Expert Rev Vaccines 2008; 7:15-20. (Pubitemid 351357962)
16. Eurosurveillance editorial team. ECDC in collaboration with the VAESCO consortium to develop a complementary tool for vaccine safety monitoring in Europe. Euro Surveill 2009; 14:19345. Available online: http://www. eurosurveillance.org/ViewArticle. aspx?ArticleId=19345.